138 related articles for article (PubMed ID: 15701851)
1. Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray study.
Schneider-Stock R; Boltze C; Lasota J; Peters B; Corless CL; Ruemmele P; Terracciano L; Pross M; Insabato L; Di Vizio D; Iesalnieks I; Dirnhofer S; Hartmann A; Heinrich M; Miettinen M; Roessner A; Tornillo L
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):638-45. PubMed ID: 15701851
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria.
Huang HY; Huang WW; Lin CN; Eng HL; Li SH; Li CF; Lu D; Yu SC; Hsiung CY
Ann Surg Oncol; 2006 Dec; 13(12):1633-44. PubMed ID: 17013685
[TBL] [Abstract][Full Text] [Related]
3. Role for p16(INK4a) in progression of gastrointestinal stromal tumors of the stomach: alteration of p16(INK4a) network members.
Mitomi H; Fukui N; Kishimoto I; Tanabe S; Kikuchi S; Saito T; Hayashi T; Yao T
Hum Pathol; 2011 Oct; 42(10):1505-13. PubMed ID: 21496871
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic value of P16 gene methylation and P16 protein expression in gastrointestinal stromal tumor].
Liang JF; Zheng HX; Li N; Cheng CX; Xiao H; Wang HK
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jul; 10(4):372-5. PubMed ID: 17659467
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications.
Sabah M; Cummins R; Leader M; Kay E
Hum Pathol; 2006 Jun; 37(6):648-55. PubMed ID: 16733203
[TBL] [Abstract][Full Text] [Related]
6. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients.
Song Z; Wang JL; Pan YL; Tao DY; Gan MF; Huang KE
Hepatogastroenterology; 2009; 56(89):149-53. PubMed ID: 19453047
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
[TBL] [Abstract][Full Text] [Related]
9. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors].
Liang YM; Li XH; Chen W
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1041-5. PubMed ID: 18754437
[TBL] [Abstract][Full Text] [Related]
10. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy.
Keun Park C; Lee EJ; Kim M; Lim HY; Choi DI; Noh JH; Sohn TS; Kim S; Kim MJ; Lee HK; Kim KM
Ann Surg; 2008 Jun; 247(6):1011-8. PubMed ID: 18520229
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal stromal tumors--frequency, malignancy, and new prognostic factors: the experience of a single institution.
Bertolini V; Chiaravalli AM; Klersy C; Placidi C; Marchet S; Boni L; Capella C
Pathol Res Pract; 2008; 204(4):219-33. PubMed ID: 18304753
[TBL] [Abstract][Full Text] [Related]
12. Correlation of enhanced cell turnover with prognosis of gastrointestinal stromal tumors of the stomach: relevance of cellularity and p27kip1.
Nemoto Y; Mikami T; Hana K; Kikuchi S; Kobayashi N; Watanabe M; Okayasu I
Pathol Int; 2006 Dec; 56(12):724-31. PubMed ID: 17096729
[TBL] [Abstract][Full Text] [Related]
13. The cyclin-dependent kinase inhibitor, p27, has no correlation with the malignant potential of GIST.
Shirin H; Kravtsov V; Shahmurov M; Shabat VS; Krinshpon I; Alin A; Avinoach I; Avni Y
Digestion; 2007; 75(1):4-9. PubMed ID: 17406118
[TBL] [Abstract][Full Text] [Related]
14. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade.
Nakamura N; Yamamoto H; Yao T; Oda Y; Nishiyama K; Imamura M; Yamada T; Nawata H; Tsuneyoshi M
Hum Pathol; 2005 Jul; 36(7):828-37. PubMed ID: 16084954
[TBL] [Abstract][Full Text] [Related]
16. Surgical management and clinical outcome of gastrointestinal stromal tumor of the colon and rectum.
Chen CW; Wu CC; Hsiao CW; Fang FC; Lee TY; Che FC; Tsai WC; Jao SW
Z Gastroenterol; 2008 Aug; 46(8):760-5. PubMed ID: 18759198
[TBL] [Abstract][Full Text] [Related]
17. Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression.
Liegl B; Hornick JL; Antonescu CR; Corless CL; Fletcher CD
Am J Surg Pathol; 2009 Feb; 33(2):218-26. PubMed ID: 18830121
[TBL] [Abstract][Full Text] [Related]
18. [Study of loss of heterozygosity at 9p21 and P16 expression in gastrointestinal stromal tumors].
Zhang Y; Cao H; Wang M; Shen DP; Ni XZ; Wu ZY; Shen YY; Song YY
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Oct; 13(10):762-5. PubMed ID: 20972908
[TBL] [Abstract][Full Text] [Related]
19. Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).
Martín J; Poveda A; Llombart-Bosch A; Ramos R; López-Guerrero JA; García del Muro J; Maurel J; Calabuig S; Gutierrez A; González de Sande JL; Martínez J; De Juan A; Laínez N; Losa F; Alija V; Escudero P; Casado A; García P; Blanco R; Buesa JM;
J Clin Oncol; 2005 Sep; 23(25):6190-8. PubMed ID: 16135486
[TBL] [Abstract][Full Text] [Related]
20. Loss of p16 expression is of prognostic significance in locally advanced prostate cancer: an analysis from the Radiation Therapy Oncology Group protocol 86-10.
Chakravarti A; Heydon K; Wu CL; Hammond E; Pollack A; Roach M; Wolkov H; Okunieff P; Cox J; Fontanesi J; Abrams R; Pilepich M; Shipley W;
J Clin Oncol; 2003 Sep; 21(17):3328-34. PubMed ID: 12947069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
